ProQR Therapeutics (PRQR) EBT Margin Growth (3y) (2016 - 2026)
ProQR Therapeutics (PRQR) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 69,362.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,362.00 |
| Dec 31, 2025 | 163,342.00 |
| Sep 30, 2025 | 247,254.00 |
| Jun 30, 2025 | 112,903.00 |
| Mar 31, 2025 | 101,743.00 |
| Dec 31, 2024 | 740,655.00 |
| Sep 30, 2024 | 151,310.00 |
| Jun 30, 2024 | 641,504.00 |
| Mar 31, 2024 | -6,783.00 |
| Dec 31, 2023 | -9,401.00 |
| Sep 30, 2023 | -27,788.00 |
| Jun 30, 2023 | -54,318.00 |
| Mar 31, 2023 | -125,435.00 |
| Dec 31, 2022 | -174,098.00 |
| Sep 30, 2022 | -276,376.00 |
| Jun 30, 2022 | -134,905.00 |
| Mar 31, 2022 | -115,202.00 |
| Dec 31, 2021 | -752,160.00 |
| Sep 30, 2021 | -162,283.00 |
| Jun 30, 2021 | -636,441.00 |